SAN DIEGO–(BUSINESS WIRE)– #Medtech–Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that it has won the 2026 MedTech Innovator Mid-Stage Grand Prize, receiving $200,000 in non-dilutive funding. The award recognizes the company’s achievements in developing and commercializing vMap®, its FDA-cleared, non-invasive arrhythmia localization technology.MedTech Innovator, the world’s largest accelerator of medical technology companies, selected its 2026 cohort
See full post here as originally published on this site
